Cosmos Health (COSM) Capital Leases (2019 - 2025)
Cosmos Health's (COSM) quarterly Capital Leases came in at $1788.0 in Q1 2025, down 82.35% on a YoY basis from $10129.0 in Q1 2024, and down 47.4% quarter-over-quarter from $3399.0 in Q4 2024.
Powered by 
Analysis
Cosmos Health (COSM) Capital Leases (2019 - 2025) Analysis & Trends
Cosmos Health (COSM) has reported Capital Leases for 7 consecutive years, with $1788.0 the latest figure, recorded in Q1 2025.
- For the quarter ending Q1 2025, Capital Leases fell 82.35% year-over-year to $1788.0; the trailing twelve-month figure through Mar 2025 stood at $1788.0 (down 82.35% YoY), and the FY2024 full-year result was $3399.0, down 35.39% from the prior year.
- Capital Leases slipped to $1788.0 in Q1 2025 per COSM's latest filing, from $3399.0 in the prior quarter.
- Across five years, Capital Leases topped out at $305250.0 in Q2 2023 and bottomed at $1788.0 in Q1 2025.
- Historically, Capital Leases has averaged $119380.7 across 5 years, with a median of $139708.5 in 2021.
- The sharpest annual moves came in 2021 and 2024: Capital Leases soared 152.47% in 2021, then slumped 97.77% in 2024.
- Over 5 years, Capital Leases stood at $148401.0 in 2021, then slumped by 78.89% to $31333.0 in 2022, then tumbled by 83.21% to $5261.0 in 2023, then slumped by 35.39% to $3399.0 in 2024, then slumped by 47.4% to $1788.0 in 2025.
- According to Business Quant data, Capital Leases over the past three periods registered $1788.0, $3399.0, and $5845.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 1,788.00 |
| Dec 31, 2024 | 3,399.00 |
| Sep 30, 2024 | 5,845.00 |
| Jun 30, 2024 | 7,857.00 |
| Mar 31, 2024 | 10,129.00 |
| Dec 31, 2023 | 5,261.00 |
| Sep 30, 2023 | 262,103.00 |
| Jun 30, 2023 | 305,250.00 |
| Mar 31, 2023 | 279,674.00 |
| Dec 31, 2022 | 31,333.00 |
| Jun 30, 2022 | 167,187.00 |
| Mar 31, 2022 | 131,016.00 |
| Dec 31, 2021 | 148,401.00 |
| Sep 30, 2021 | 182,169.00 |
| Jun 30, 2021 | 180,134.00 |
| Mar 31, 2021 | 188,545.00 |
| Dec 31, 2020 | 188,172.00 |
| Sep 30, 2020 | 146,376.00 |
| Jun 30, 2020 | 108,947.00 |
| Mar 31, 2020 | 74,681.00 |